跳至主要内容
临床试验/NCT05170035
NCT05170035招募中不适用

Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery - A Randomized Controlled Trial

Bispebjerg Hospital1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2022年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
26
试验地点
1
主要终点
Blinded assesment of wound healing at day 18-20.

研究概览

简要总结

The primary objects of this study is to explore the potential effect of the autologous patch to optimize wound healing after skin cancer surgery with Mohs micrographic surgery (MMS) in the face in a randomized controlled trial comparing autologous patch healing versus secondary intention healing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Blinded photo assesment of wound healing by two independent trained clinical doctors.

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects undergoing MMS for biopsy verified primary nodular basal cell carcinoma in the face, head and neck area on a location suitable for secondary intention healing and thus may also be suitable for autologous patch healing
  • Presenting relevant medical record report at study initiation
  • Written informed consent obtained from subject
  • Understanding of investigation procedures and willingness to abide to all procedures during the course of the investigation.

排除标准

  • A subjects with major systemic disease not yet stabilized
  • Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
  • Pregnant or breast feeding
  • Unable to follow the outlined study protocol
  • Participation in other studies at the same time that may affect the wound healing.

结局指标

主要结局

Blinded assesment of wound healing at day 18-20.

时间窗: Day 18-20

Two indenpendent trained clinical doctors will evaluate clinical photos. Wounds will be evaluated fully epithelialized yes/no.

次要结局

  • Blinded assesment of wound healing at day 11-13(day 11-13)
  • Difference in microbiology between intervention wounds and control wounds.(day 1 and day 11-13)
  • Scar evaluation using the patient-observer-scar-assesment-scale (POSAS) at 6 months follow-up.(6 months)
  • TEWL measurement(day 11-13 and day 18-20)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katrine Elisabeth Karmisholt

MD, Chief Consultant, Ass.Prof., PhD

Bispebjerg Hospital

研究点 (1)

Loading locations...

相似试验